Literature DB >> 31806654

The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE.

Nishant P Shah1, Qiuqing Wang2,3, Katherine E Wolski2,3, Leslie Cho2, Ellen McErlean3, Giacomo Ruotolo4, Govinda Weerakkody4, Jeffrey S Riesmeyer4, Stephen J Nicholls5, A Michael Lincoff2,3, Steven E Nissen2,3, Venu Menon6,3.   

Abstract

Entities:  

Year:  2019        PMID： 31806654     DOI： 10.2337/dc19-1117

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  4 in total

1.  Study on the relationship between hormone and Lp(a) in Chinese overweight/obese patients.

Authors:  Xiaona Chang; Nannan Bian; Xiaoyu Ding; Jinman Li; Yu An; Jiaxuan Wang; Jia Liu; Guang Wang
Journal:  BMC Endocr Disord       Date:  2022-05-16       Impact factor: 3.263

2.  How Do Lipoprotein(a) Concentrations Affect Clinical Outcomes for Patients With Stable Coronary Artery Disease Who Underwent Different Dual Antiplatelet Therapy After Percutaneous Coronary Intervention?

Authors:  Kongyong Cui; Dong Yin; Chenggang Zhu; Weihua Song; Hongjian Wang; Lei Jia; Rui Zhang; Haoyu Wang; Zhongxing Cai; Lei Feng; Kefei Dou
Journal:  J Am Heart Assoc       Date:  2022-04-27       Impact factor: 6.106

3.  Benefit and Risk of Prolonged Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents in Patients With Elevated Lipoprotein(a) Concentrations.

Authors:  Kongyong Cui; Hao-Yu Wang; Dong Yin; Chenggang Zhu; Weihua Song; Hongjian Wang; Lei Jia; Dong Zhang; Chenxi Song; Lei Feng; Kefei Dou
Journal:  Front Cardiovasc Med       Date:  2021-12-20

Review 4.  A New Look at Novel Cardiovascular Risk Biomarkers: The Role of Atherogenic Lipoproteins and Innovative Antidiabetic Therapies.

Authors:  Jelena Vekic; Aleksandra Zeljkovic; Khalid Al Rasadi; Mustafa Cesur; José Silva-Nunes; Anca Pantea Stoian; Manfredi Rizzo
Journal:  Metabolites       Date:  2022-01-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.